Sotex
Sotex is a Moscow-based Russian full-cycle pharmaceutical manufacturer specializing in injectable and biotechnological drugs, operating as the production core of PROTEK Group. It supplies 150+ products across neurology, oncology, and nephrology to government healthcare programs and exports to 20 countries including EU member states.
- Company typePrivate
- Founded1999
- HeadquartersMoscow, Russia
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sotex does
Sotex (ZAO PharmFirma Sotex) is a Russian full-cycle pharmaceutical manufacturer founded in 1999 and headquartered in Moscow. Operating as the foundation of the production segment of PROTEK Group, a diversified pharmaceutical conglomerate, the company specializes in injectable drugs — ampoules, prefilled syringes with needle protection devices, and biotechnological products — across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology. Its Belikovo production facility in the Moscow region, commissioned in 2005 and built to EU GMP standards, produces 143 million ampoules and 13 million prefilled syringes annually, and the company holds European GMP certifications from Croatia and Portugal as well as EAEU GMP certification from the Russian Ministry of Industry and Trade. The portfolio exceeds 150 product positions including the proprietary original drug Tafalgin, with more than 50 products in the R&D pipeline, and through its Rafarma subsidiary (acquired 2011) the group extends into oncological drugs, antibiotics, and contract manufacturing for third parties.
Sotex generates revenue primarily through pharmaceutical product sales via two channels: Russian state procurement under the Essential Medicines List (ZhNVLP) through competitive tenders, and commercial distribution to hospitals, clinics, and pharmacies across all regions of Russia. The company has confirmed full production cycle status for 169 international non-proprietary names and ranks 5th among Russian full-cycle pharmaceutical manufacturers in government procurement per Minpromtorg, placing it within a 116.9 billion ruble state procurement pool in 2025. The second growth vector is international — products are exported to 20 countries including EU member states, with the first EU shipment completed in 2023 and Belarus market entry in 2024. The go-to-market motion combines medical representative engagement with healthcare professionals, government tender participation, and channel distribution partnerships with international pharmaceutical companies including Synthon, Intas, Emcure, Glenmark, and Pharos. PROTEK Group's holding structure provides Sotex with access to complementary subsidiaries (Rafarma, AnviLab, Protein Contour, Protek-SVM, BION) that expand the addressable product surface beyond Sotex's own injectable specialization.
Sotex firmographics
Firmographics- Name
- Sotex
- Legal name
- ЗАО "ФармФирма "Сотекс"
- Website
- https://sotex.ru
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Sotex is a Moscow-based Russian full-cycle pharmaceutical manufacturer specializing in injectable and biotechnological drugs, operating as the production core of PROTEK Group. It supplies 150+ products across neurology, oncology, and nephrology to government healthcare programs and exports to 20 countries including EU member states.
- Ownership category
- akta.pro rank
Sotex industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)
- akta.pro secondary industries
- Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG), Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces) (HLAAAJAG)
Keywords
Where Sotex is headquartered
LocationHeadquarters
- HQ city
- Moscow
- HQ country
- Russia
- HQ region
- Europe
Offices3 records
Markets served
Sotex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical product sales: Sale of pharmaceutical products across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology. Products are sold through government procurement (state tenders) and commercial distribution channels. The company has a portfolio of more than 150 product positions.
- Contract manufacturing: Rafarma offers contract manufacturing services to third-party pharmaceutical companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Government procurement / regulated pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Sotex product offering
Product offeringCore offering
Sotex (ЗАО «ФармФирма «Сотекс») is a Russian full-cycle pharmaceutical manufacturer specializing in injectable drugs, biotechnological products, and prefilled syringes. The company produces more than 150 pharmaceutical product positions across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology, with annual capacity of 143 million ampules and 13 million prefilled syringes. Operations are GMP-certified under Russian and EU standards, and products are supplied domestically via government procurement and commercially, as well as exported to 20 countries.
Product overview
Sotex is a Russian pharmaceutical company operating as part of the PROTEK Group's production segment. The company offers a diversified portfolio of over 150 pharmaceutical products across multiple therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology. The product portfolio includes prescription and OTC drugs available in various forms: injectables (ampules, pre-filled syringes), tablets, capsules, suppositories, and gels. Key products include original medications like Тафлгин®, биотехнологические препараты such as Эральфон® (epoetin alfa), and a wide range of generic medications. The company operates two production facilities: Sotex (specializing in injectables - ampules and syringes, producing 143 million ampules and 13 million syringes annually) and Rafarma (producing oncological drugs, antibiotics, tablets, capsules, suppositories, and gels). Sotex provides contract manufacturing services and holds GMP certifications from Russian and EU regulatory bodies.
Differentiator
Problem solved
Functional benefit
Products and services
- Eralfon (Эральфон®) Recombinant erythropoietin (epoetin alfa) in prefilled syringe form for the treatment of anemia in oncology and nephrology patients. For healthcare providers and patients.
- Tafalgin (Тафалгин®) Original proprietary drug developed and registered by Sotex in injectable form.
- Amelotex (Амелотекс®)
Quantifiable outcome
- 143 million ampules produced annually
- +4 more outcomes
Companies that use Sotex
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles3 records
Sotex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Sotex partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered key, core and flagship.
- SynthonkeySynthon is an international science-oriented pharmaceutical company. Sotex collaborates with Synthon on the Russian market development and distribution of pharmaceutical products.
- Intas PharmaceuticalskeyIntas is a pharmaceutical company engaged in the development, manufacturing and marketing of a wide range of biopharmaceutical products worldwide. Sotex collaborates with Intas on the Russian market.
- Emcure PharmaceuticalskeyEmcure is engaged in the development, manufacturing and marketing of biopharmaceutical products worldwide. Sotex collaborates with Emcure on the Russian market.
- Pharos Pharmaceutical GroupcorePharos is an international pharmaceutical company. Sotex collaborates with Pharos on the Russian market.
- Glenmark PharmaceuticalscoreGlenmark is an international pharmaceutical company specializing in R&D. Sotex collaborates with Glenmark on the Russian market.
- RafarmakeyRafarma (AO Rafarma) is a production subsidiary of GK Protek, producing oncological drugs and antibiotics at full cycle. Companies jointly develop target education programs, organize professional orientation events for schoolchildren, and participate in joint initiatives including FarmFest festival and GxP-Fest.
- GK Protek (ГК Протек)flagshipGK Protek is the parent holding company of Sotex and the production segment it anchors. Protek Group includes companies: Sotex, Rafarma, AnviLab, Protein Contour, Protek-SVM, BION, and strategic partner Active Component. Sotex is the foundation of the production segment of GK Protek.
- Евразийская академия надлежащих практик (ANO EANP)coreEurasian Academy of Good Practices provides educational programs, supports GxP-Fest and FarmFest festivals, and collaborated on VR training complex development. One of the first organizations to partner with Sotex on innovative training technologies.
- Благотворительный фонд «Протек»keyCharitable Foundation of Protek Group implements charity programs including 'Along the Path of Mercy' program. Joint activities with Sotex include support for children's, medical and educational institutions.
- ФБУ ГИЛС и НП (Государственный институт лекарственных средств и надлежащих практик)coreFederal Budgetary Institution for pharmaceutical industry development. GLLS&NP organizes the GxP-Fest festival and serves as the Russian GMP inspectorate under the Ministry of Industry and Trade. Company CEO Vadim Yatsuk spoke at a GxP-Fest session on digital development in pharma.
Scale indicators13 records
Recent moves6 records
Expansion highlights6 records
Sotex competitors and assessment
Company assessmentDirect peers
- Generium: Russian biotech manufacturer focused on biosimilars, blood products, and complex injectables. Comparable to Sotex in biopharmaceutical manufacturing capability and prefilled syringe/aseptic fill-finish expertise.
- Akrikhin: Russian full-cycle manufacturer of generics and branded generics (Polpharma subsidiary). Competes directly with Sotex in Russian state procurement and shares similar reliance on ZhNVLP pricing and contract manufacturing exposure.
- Biocad: Russian biotech company developing and manufacturing biosimilars, mAbs, and ATMPs. Comparable to Sotex in prefilled syringe biotech manufacturing and government channel for biological products, though more biologics-concentrated.
- Polysan: Russian pharmaceutical manufacturer with branded generics in neurology, infectious disease, and immunology. Comparable therapeutic-area focus and similar mid-tier scale in Russian state procurement.
- Valenta Pharm: Russian full-cycle pharmaceutical manufacturer with branded prescription portfolio spanning neurology, immunology, and anti-infectives. Directly comparable in scale, therapeutic focus, and ZhNVLP government channel exposure.
- Pharmstandard: Russia's largest full-cycle pharmaceutical manufacturer, listed on the Moscow Exchange. Competes with Sotex across prescription generics, injectables, and Essential Medicines List procurement in the same therapeutic categories.
- Vertex (Veropharm): Russian pharmaceutical manufacturer of generic injectables, tablets, and oncology products (Abbott subsidiary). Direct overlap with Sotex in injectable generics and government procurement participation.
Emerging players
- NovaMedica: Russian pharmaceutical development and manufacturing company with R-Pharm backing. Smaller scale but overlapping in injectable pharmaceutical manufacturing and partnership-based business model.
- Obolenskoe Pharmaceutical Enterprise: Russian manufacturer of finished dosage forms including injectables and solid forms. Competes in similar generics categories and ZhNVLP tenders, though at smaller scale than Sotex.
Broad incumbents
- R-Pharm: One of Russia's largest pharmaceutical groups with operations spanning manufacturing, R&D, and distribution. Larger and more diversified than Sotex but competes in the same full-cycle generics and biologics categories.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Sotex social profiles
Digital presenceSotex compliance and trust
Trust signalCompliance3 records
Sotex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sotex leadership team
Management profileNumber of profiles
Profiles8 records
Sotex subsidiaries and ownership
Company hierarchySubsidiaries2 records
Sotex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sotex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sotex
What does Sotex do?
Sotex (ЗАО «ФармФирма «Сотекс») is a Russian full-cycle pharmaceutical manufacturer specializing in injectable drugs, biotechnological products, and prefilled syringes. The company produces more than 150 pharmaceutical product positions across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology, with annual capacity of 143 million ampules and 13 million prefilled syringes. Operations are GMP-certified under Russian and EU standards, and products are supplied domestically via government procurement and commercially, as well as exported to 20 countries.
Is Sotex a public or private company?
Sotex is a private company. It is classified as corporate owned and is currently operating.
When was Sotex founded?
Sotex was founded in 1999. It employs 501 to 1,000 people.
Where is Sotex based?
Sotex is headquartered in Moscow, Russia, in the Europe region.
How does Sotex make money?
Two revenue lines are on record. Pharmaceutical product sales are the primary driver. The others are contract manufacturing.
Who are Sotex's main competitors?
Direct peers on record are Generium, Akrikhin, Biocad, Polysan, Valenta Pharm, Pharmstandard and Vertex (Veropharm). Emerging players are NovaMedica and Obolenskoe Pharmaceutical Enterprise. R-Pharm is listed as a broad incumbent.
Does Sotex have an API?
No public API is recorded for Sotex.
What industry is Sotex in?
Sotex's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAAAKAB, Drug Product Fill-Finish & Aseptic Manufacturing Services, with a secondary code of HLAGAGAG, Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP). Its NAICS code is 325412 and its SIC code is 2834.